News Column

Studies from L. Gastaldi and Co-Authors Have Provided New Information about Nanoparticles (Solid lipid nanoparticles as vehicles of drugs to the...

September 12, 2014



Studies from L. Gastaldi and Co-Authors Have Provided New Information about Nanoparticles (Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art)

By a News Reporter-Staff News Editor at Drug Week -- Research findings on Nanoparticles are discussed in a new report. According to news originating from Turin, Italy, by NewsRx correspondents, research stated, "Central nervous system disorders are already prevalent and steadily increasing among populations worldwide."

Our news journalists obtained a quote from the research, "However, most of the pharmaceuticals present on world markets are ineffective in treating cerebral diseases, because they cannot effectively cross the blood brain barrier (BBB). Solid lipid nanopartides (SLN) are nanospheres made from biocompatible solid lipids, with unique advantages among drug carriers: they can be used as vehicles to cross the BBB."

According to the news editors, the research concluded: "This review examines the main aspects surrounding brain delivery with SLN, and illustrates the principal mechanisms used to enhance brain uptake of the delivered drug."

For more information on this research see: Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art. European Journal of Pharmaceutics and Biopharmaceutics, 2014;87(3):433-444. European Journal of Pharmaceutics and Biopharmaceutics can be contacted at: Elsevier Science Bv, PO Box 211, 1000 Ae Amsterdam, Netherlands. (Elsevier - www.elsevier.com; European Journal of Pharmaceutics and Biopharmaceutics - www.elsevier.com/wps/product/cws_home/600120)

The news correspondents report that additional information may be obtained from L. Gastaldi, Dipartimento Sci & Tecnol Farmaco, Turin, Italy. Additional authors for this research include L. Battaglia, E. Peira, D. Chirio, E. Muntoni, I. Solazzi, M. Gallarate and F. Dosio (see also Nanoparticles).

Keywords for this news article include: Turin, Italy, Europe, Emerging Technologies, Nanoparticle, Nanoparticles, Nanotechnology

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Drug Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters